These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32202562)

  • 1. [Palliative inotrope therapy in advanced heart failure: organization and management].
    Gorni G; Correale M; Nodari S; Sinagra G
    G Ital Cardiol (Rome); 2020 Apr; 21(4):296-302. PubMed ID: 32202562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    López-Candales AL; Carron C; Schwartz J
    Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory Inotrope Infusions in Advanced Heart Failure: A Systematic Review and Meta-Analysis.
    Nizamic T; Murad MH; Allen LA; McIlvennan CK; Wordingham SE; Matlock DD; Dunlay SM
    JACC Heart Fail; 2018 Sep; 6(9):757-767. PubMed ID: 30007556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
    Malotte K; Saguros A; Groninger H
    J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes for patients with nonischemic cardiomyopathy taking intravenous inotropes versus those weaned from or never taking inotropes at cardiac resynchronization therapy.
    Adelstein E; Bhattacharya S; Simon MA; Gorcsan J; Saba S
    Am J Cardiol; 2012 Sep; 110(6):857-61. PubMed ID: 22681865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative Inotrope Therapy: A Narrative Review.
    Chuzi S; Allen LA; Dunlay SM; Warraich HJ
    JAMA Cardiol; 2019 Aug; 4(8):815-822. PubMed ID: 31268467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based Strategies for Advanced Heart Failure.
    White SM
    Crit Care Nurs Clin North Am; 2019 Mar; 31(1):1-13. PubMed ID: 30736930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients: A Systematic Review and Meta-Analysis.
    Hernandez GA; Blumer V; Arcay L; Monge J; Viles-Gonzalez JF; Lindenfeld J; Goldberger JJ; Chaparro S
    JACC Heart Fail; 2018 Sep; 6(9):734-742. PubMed ID: 30098968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of positive inotropes in end-of-life heart failure care.
    Nauman DJ; Hershberger RE
    Curr Heart Fail Rep; 2007 Sep; 4(3):158-63. PubMed ID: 17883992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.
    MacIver J; Rao V; Delgado DH; Desai N; Ivanov J; Abbey S; Ross HJ
    J Heart Lung Transplant; 2008 Sep; 27(9):1002-7. PubMed ID: 18765193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Inotrope Therapy in Hospice Care: A Case Series.
    Patel K; D'Souza A; Groninger H
    Am J Hosp Palliat Care; 2019 Jul; 36(7):660-663. PubMed ID: 30630349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home Inotropes in Patients Supported with Left Ventricular Assist Devices.
    Anyanwu EC; Kagan V; Bhatia A; Tehrani DM; Adatya S; Kim G; Sarswat N; Jeevanandam V; Sayer G; Uriel N
    ASAIO J; 2019 Jan; 65(1):e7-e11. PubMed ID: 29461278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home Therapies in Advanced Heart Failure: Inotropes and Diuretics.
    Graffagnino JP; Avant LC; Calkins BC; Swetz KM
    Curr Heart Fail Rep; 2020 Oct; 17(5):314-323. PubMed ID: 32830304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure.
    Hershberger RE; Nauman D; Walker TL; Dutton D; Burgess D
    J Card Fail; 2003 Jun; 9(3):180-7. PubMed ID: 12815567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palliative care in the cardiac setting: a consensus document of the Italian Society of Cardiology/Italian Society of Palliative Care (SIC/SICP)].
    Antonione R; Sinagra G; Moroni M; Correale M; Redaelli D; Scrutinio D; Malinverni E; Nodari S; Calabrò R; Penco I; Mercuro G
    G Ital Cardiol (Rome); 2019 Jan; 20(1):46-61. PubMed ID: 30638215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced therapies for end-stage heart failure.
    Katz JN; Waters SB; Hollis IB; Chang PP
    Curr Cardiol Rev; 2015; 11(1):63-72. PubMed ID: 24251460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing our Approach to Stage D Heart Failure.
    Becnel MF; Ventura HO; Krim SR
    Prog Cardiovasc Dis; 2017; 60(2):205-214. PubMed ID: 28801124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.